Advertisement
Home »

Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.

Apr 17, 2023

ABOUT THE EXPERTS

  • Bo-Ram Jin

    Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: wlsqh92@gmail.com.

    Hyo-Jung Kim

    Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: hyojung_95@naver.com.

    Jung-Hyun Na

    Department of Pharmaceutical Engineering, Sangji University, Wonju, Republic of Korea. Electronic address: najunghyun@sangji.ac.kr.

    Won-Kyu Lee

    New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Chungcheongbuk-do, 28160, Republic of Korea. Electronic address: gre7@kbiohealth.kr.

    Hyo-Jin An

    Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea; Department of Integrated Drug Development and Natural Products, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Electronic address: hjan@khu.ac.kr.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement